vs

Side-by-side financial comparison of AVINO SILVER & GOLD MINES LTD (ASM) and Editas Medicine, Inc. (EDIT). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $21.0M, roughly 1.2× AVINO SILVER & GOLD MINES LTD). AVINO SILVER & GOLD MINES LTD runs the higher net margin — 36.6% vs -22.7%, a 59.3% gap on every dollar of revenue. On growth, AVINO SILVER & GOLD MINES LTD posted the faster year-over-year revenue change (44.0% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 51.1%).

Avino Silver & Gold Mines Ltd is a Canada-based mining company engaged in the exploration, development, and production of precious and base metals, primarily silver, gold, and copper. It operates its flagship Avino Mine property in Durango, Mexico, with its metal products supplied to global industrial and commodity markets.

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

ASM vs EDIT — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.2× larger
EDIT
$24.7M
$21.0M
ASM
Growing faster (revenue YoY)
ASM
ASM
+63.1% gap
ASM
44.0%
-19.2%
EDIT
Higher net margin
ASM
ASM
59.3% more per $
ASM
36.6%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
51.1%
ASM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASM
ASM
EDIT
EDIT
Revenue
$21.0M
$24.7M
Net Profit
$7.7M
$-5.6M
Gross Margin
47.1%
Operating Margin
-31.3%
Net Margin
36.6%
-22.7%
Revenue YoY
44.0%
-19.2%
Net Profit YoY
558.9%
87.6%
EPS (diluted)
$0.05
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASM
ASM
EDIT
EDIT
Q4 25
$24.7M
Q3 25
$21.0M
$7.5M
Q2 25
$21.8M
$3.6M
Q1 25
$18.8M
$4.7M
Q4 24
$30.6M
Q3 24
$14.6M
$61.0K
Q2 24
$14.8M
$513.0K
Q1 24
$12.4M
$1.1M
Net Profit
ASM
ASM
EDIT
EDIT
Q4 25
$-5.6M
Q3 25
$7.7M
$-25.1M
Q2 25
$2.9M
$-53.2M
Q1 25
$5.6M
$-76.1M
Q4 24
$-45.4M
Q3 24
$1.2M
$-62.1M
Q2 24
$1.2M
$-67.6M
Q1 24
$599.0K
$-62.0M
Gross Margin
ASM
ASM
EDIT
EDIT
Q4 25
Q3 25
47.1%
Q2 25
46.9%
Q1 25
56.1%
Q4 24
Q3 24
39.1%
Q2 24
31.8%
Q1 24
18.9%
Operating Margin
ASM
ASM
EDIT
EDIT
Q4 25
-31.3%
Q3 25
-325.4%
Q2 25
-1440.6%
Q1 25
-1635.1%
Q4 24
-152.2%
Q3 24
-107649.2%
Q2 24
-14016.2%
Q1 24
-5902.3%
Net Margin
ASM
ASM
EDIT
EDIT
Q4 25
-22.7%
Q3 25
36.6%
-333.0%
Q2 25
13.1%
-1487.8%
Q1 25
29.8%
-1633.5%
Q4 24
-148.3%
Q3 24
8.0%
-101870.5%
Q2 24
8.4%
-13178.8%
Q1 24
4.8%
-5458.1%
EPS (diluted)
ASM
ASM
EDIT
EDIT
Q4 25
$0.03
Q3 25
$0.05
$-0.28
Q2 25
$0.02
$-0.63
Q1 25
$0.04
$-0.92
Q4 24
$-0.55
Q3 24
$0.01
$-0.75
Q2 24
$0.01
$-0.82
Q1 24
$0.00
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASM
ASM
EDIT
EDIT
Cash + ST InvestmentsLiquidity on hand
$57.3M
$146.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$182.1M
$27.3M
Total Assets
$221.9M
$186.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASM
ASM
EDIT
EDIT
Q4 25
$146.6M
Q3 25
$57.3M
$165.6M
Q2 25
$37.3M
$178.5M
Q1 25
$26.6M
$221.0M
Q4 24
$269.9M
Q3 24
$7.8M
$265.1M
Q2 24
$5.3M
$279.1M
Q1 24
$3.5M
$296.2M
Total Debt
ASM
ASM
EDIT
EDIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASM
ASM
EDIT
EDIT
Q4 25
$27.3M
Q3 25
$182.1M
$13.5M
Q2 25
$144.8M
$19.2M
Q1 25
$132.3M
$62.4M
Q4 24
$134.3M
Q3 24
$114.5M
$175.6M
Q2 24
$112.2M
$232.0M
Q1 24
$107.8M
$294.4M
Total Assets
ASM
ASM
EDIT
EDIT
Q4 25
$186.5M
Q3 25
$221.9M
$201.8M
Q2 25
$174.7M
$210.6M
Q1 25
$157.7M
$263.7M
Q4 24
$341.6M
Q3 24
$135.4M
$327.6M
Q2 24
$133.7M
$384.8M
Q1 24
$128.6M
$440.3M
Debt / Equity
ASM
ASM
EDIT
EDIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASM
ASM
EDIT
EDIT
Operating Cash FlowLast quarter
$8.3M
$-36.4M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASM
ASM
EDIT
EDIT
Q4 25
$-36.4M
Q3 25
$8.3M
$-30.8M
Q2 25
$8.3M
$-50.2M
Q1 25
$758.0K
$-47.8M
Q4 24
$-50.8M
Q3 24
$4.1M
$-52.6M
Q2 24
$1.1M
$-57.1M
Q1 24
$2.3M
$-49.9M
Free Cash Flow
ASM
ASM
EDIT
EDIT
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
Q1 25
$-47.9M
Q4 24
$-51.3M
Q3 24
$-55.5M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
ASM
ASM
EDIT
EDIT
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
Q1 25
-1028.6%
Q4 24
-167.6%
Q3 24
-90998.4%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
ASM
ASM
EDIT
EDIT
Q4 25
0.2%
Q3 25
5.7%
Q2 25
0.0%
Q1 25
2.4%
Q4 24
1.8%
Q3 24
4788.5%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
ASM
ASM
EDIT
EDIT
Q4 25
Q3 25
1.08×
Q2 25
2.92×
Q1 25
0.13×
Q4 24
Q3 24
3.55×
Q2 24
0.87×
Q1 24
3.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons